Holen Sie sich die Stockscreener-App
2.62
5.76%
-0.16
Vorhandelsmarkt:
2.62
Schlusskurs vom Vortag:
$2.78
Offen:
$2.75
24-Stunden-Volumen:
213.40K
Relative Volume:
1.08
Marktkapitalisierung:
$6.57M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.6764
EPS:
-3.8732
Netto-Cashflow:
$-14.65M
1W Leistung:
-5.76%
1M Leistung:
-16.83%
6M Leistung:
-18.38%
1J Leistung:
-47.39%
1-Tages-Spanne:
$2.521
$2.78
1-Wochen-Bereich:
$2.521
$2.91
52-Wochen-Spanne:
$1.71
$8.5961
Sintx Technologies Inc Stock (SINT) Company Profile
Firmenname
Sintx Technologies Inc
Sektor
Branche
Telefon
801-839-3516
Adresse
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Vergleichen Sie SINT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.62 | 6.97M | 1.23M | -8.26M | -14.65M | -3.8732 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-12 | Eingeleitet | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Aktie (SINT) Neueste Nachrichten
What analysts say about Sintx Technologies Inc. stockUnprecedented profits - jammulinksnews.com
SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices - The Manila Times
Sintx Technologies Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
Is Sintx Technologies Inc. a good long term investmentHigh-yield investments - PrintWeekIndia
What drives Sintx Technologies Inc. stock priceFree Investment Case Studies - Autocar Professional
How Sintx Technologies Inc. stock reacts to Fed policy changesHigh Reward Risk Balanced Trading - Newser
What makes Sintx Technologies Inc. stock price move sharplyTriple Return With Stability - Newser
Sintx Technologies (NASDAQ:SINT) Stock Price Down 10.8% – Here’s Why - Defense World
How Sintx Technologies Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser
Why Sintx Technologies Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser
SINTX Technologies Plunges 10.1% Amid Boeing 787 Crash Concerns - AInvest
SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings - Nasdaq
SINTX acquires SiNAPTIC’s surgical assets to expand foot and ankle market - Investing.com
SINTX Technologies (SINT) Enhances Strategic Vision to Boost Gro - GuruFocus
SINTX Technologies outlines new strategy to commercialize silicon nitride By Investing.com - Investing.com South Africa
SINTX Technologies Unveils Strategic Vision To Expand Commercialization Across Key Markets - Nasdaq
SINTX Technologies outlines new strategy to commercialize silicon nitride - Investing.com
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | SINT Stock News - GuruFocus
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors - GlobeNewswire
Sintx Technologies (NASDAQ:SINT) Price Target Lowered to $28.00 at Ascendiant Capital Markets - Defense World
SINTX Technologies (SINT) Rating Maintained as Price Target Adju - GuruFocus
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating By Investing.com - Investing.com South Africa
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating - Investing.com India
SINTX Technologies (SINT) Rating Maintained as Price Target Adjusted | SINT Stock News - GuruFocus
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary - MSN
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary By Stocktwits - Investing.com India
SINTX Technologies expands into agribiotech with new patent - Investing.com Australia
SINTX Technologies expands into agribiotech with new patent By Investing.com - Investing.com South Africa
SINTX Technologies Receives Patent for Antimicrobial Agribiotech Product - mg Magazine
SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market - Koreabizwire
SINTX (SINT) Expands into Agribiotech with New Patent and Subsid - GuruFocus
Finanzdaten der Sintx Technologies Inc-Aktie (SINT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):